Uric acid levels have no significant effect on renal function in adult renal transplant recipients: Evidence from the symphony study

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 10, 2009, Pages 1655-1660

  Meier Kriesche, Herwig Ulf ^a   Schold, Jesse D ^a   Vanrenterghem, Yves ^b   Halloran, Philip F ^c   Ekberg, Henrik ^d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF ALBERTA   (Canada)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CLINICAL TRIAL; CREATININE CLEARANCE; DIALYSIS; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; SENSITIVITY ANALYSIS; URIC ACID BLOOD LEVEL;

ADULT; AGED; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; URIC ACID;

EID: 73349142001     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02700409     Document Type: Article

References (17)

1. Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, Kestenbaum B, Carney JK, Fried LF: Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 50: 239-247, 2007
2. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S: Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44: 642-650, 2004
3. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ: A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13: 2888-2897, 2002
4. Kang DH, Nakagawa T: Uric acid and chronic renal disease: Possible implication of hyperuricemia on progression of renal disease. Semin Nephrol 25: 43-49, 2005
5. Johnson RJ, Segal MS, Srinivas T, Ejaz A, Mu W, Roncal C, Sanchez-Lozada LG, Gersch M, Rodriguez-Iturbe B, Kang DH, Acosta JH: Essential hypertension, progressive renal disease, and uric acid: A pathogenetic link? J Am Soc Nephrol 16: 1909-1919, 2005
6. Siu YP, Leung KT, Tong MK, Kwan TH: Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47: 51-59, 2006
7. Kanbay M, Akcay A, Huddam B, Usluogullari CA, Arat Z, Ozdemir FN, Haberal M: Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Transplant Proc 37: 3119-3120, 2005
8. Lin HY, Rocher LL, McQuillan MA, Schmaltz S, Palella TD, Fox IH: Cyclosporine-induced hyperuricemia and gout. N Engl J Med 321: 287-292, 1989
9. Morales JM, Wramner L, Kreis H, Durand D, Campistol JM, Andres A, Arenas J, Negre E, Burke JT, Groth CG: Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients. Am J Transplant 2: 436-442, 2002
10. Gerhardt U, Grosse HM, Hohage H: Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients. Clin Transplant 13: 375-379, 1999
11. Armstrong KA, Johnson DW, Campbell SB, Isbel NM, Hawley CM: Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients? Transplantation 80: 1565-1571, 2005
12. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR: The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326-2333, 2003
13. Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A, Margreiter R, Hugo C, Grinyo JM, Frei U, Vanrenterghem Y, Daloze P, Halloran PF: Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 357: 2562-2575, 2007
14. Mazzali M: Uric acid and transplantation. Semin Nephrol 25: 50-55, 2005
15. Perico N, Codreanu I, Caruso M, Remuzzi G: Hyperuricemia in kidney transplantation. Contrib Nephrol 147: 124-131, 2005
16. Akgul A, Bilgic A, Ibis A, Ozdemir FN, Arat Z, Haberal M: Is uric acid a predictive factor for graft dysfunction in renal transplant recipients? Transplant Proc 39: 1023-1026, 2007
17. Hsu SP, Pai MF, Peng YS, Chiang CK, Ho TI, Hung KY: Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant 19: 457-462, 2004